Inventor · disambiguated record
Mark A. Youngman
Also filed as: YOUNGMAN MARK · YOUNGMAN MARK A · YOUNGMAN MARK ANDREW
43 granted patents·8 pending applications·468 citations·filing 1999–2020
98Inventor score
Files withPURDUE PHARMA LP17JANSSEN PHARMACEUTICA NV8ORTHO MCNEIL PHARM INC6COLBURN RAYMOND W4CODD ELLEN3
Top patents by PatentIndex Score
51 records- 0194US6140354AN-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 1999·Granted Oct 31, 2000·152 cites·22 claims
- 0293US9163008B2Pyrimidines as sodium channel blockersNI CHIYOU·Filed 2012·Granted Oct 20, 2015·34 cites·21 claims
- 0392US6380224B1Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 2000·Granted Apr 30, 2002·46 cites·9 claims
- 0491US9273048B2Spirocyclic morphinans and their usePURDUE PHARMA LP·Filed 2015·Granted Mar 1, 2016·11 cites·18 claims
- 0591US8987287B2Spirocyclic morphinans and their usePURDUE PHARMA LP·Filed 2013·Granted Mar 24, 2015·15 cites·31 claims
- 0688US9403824B2Pyridonemorphinan analogs and biological activity on opioid receptorsPURDUE PHARMA LP·Filed 2015·Granted Aug 2, 2016·8 cites·18 claims
- 0788US9175000B2Buprenorphine analogsPURDUE PHARMA LP·Filed 2013·Granted Nov 3, 2015·11 cites·47 claims
- 0888US8809327B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2012·Granted Aug 19, 2014·13 cites·5 claims
- 0988US8324217B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2012·Granted Dec 4, 2012·13 cites·11 claims
- 1088US8153682B2Sulfonamides as TRPM8 modulatorsBRANUM SHAWN T·Filed 2008·Granted Apr 10, 2012·16 cites·37 claims
- 1188US8143259B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Mar 27, 2012·13 cites·24 claims
- 1286US9656959B2Substituted pyridines as sodium channel blockersNI CHIYOU·Filed 2011·Granted May 23, 2017·11 cites·24 claims
- 1386US8653099B2Cold menthol receptor antagonistsCOLBURN RAYMOND W·Filed 2009·Granted Feb 18, 2014·9 cites·27 claims
- 1484US6984647B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jan 10, 2006·15 cites·51 claims
- 1583US7951829B2Benzimidazole modulators of VR1JANSSEN PHARMACEUTICA NV·Filed 2007·Granted May 31, 2011·6 cites·17 claims
- 1683US7678812B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 16, 2010·5 cites·4 claims
- 1783US7358261B2Heteroaryl alkylamide derivatives useful as bradykinin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2004·Granted Apr 15, 2008·17 cites·10 claims
- 1882US9656968B2Pyrimidines as sodium channel blockersPURDUE PHARMA LP·Filed 2015·Granted May 23, 2017·3 cites·14 claims
- 1981US8569505B2Aminotetralin-derived urea modulators of vanilloid VR1 receptorCODD ELLEN·Filed 2010·Granted Oct 29, 2013·5 cites·52 claims
- 2080US10059675B2Pyrimidines as sodium channel blockersPURDUE PHARMA LP·Filed 2017·Granted Aug 28, 2018·2 cites·21 claims
- 2180US7897781B2Cold menthol receptor-1 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 1, 2011·6 cites·39 claims
- 2277US8394828B2Quinoline-derived amide modulators of vanilloid VR1 receptorCODD ELLEN·Filed 2008·Granted Mar 12, 2013·3 cites·142 claims
- 2374US7183411B2Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptorJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Feb 27, 2007·7 cites·5 claims
- 2474US6201025B1N-aralkylaminotetralins as ligands for the neuropeptide Y Y5 receptorORTHO MCNEIL PHARM INC·Filed 1999·Granted Mar 13, 2001·35 cites·16 claims
- 2572US9637458B2Pyrimidine carboxamides as sodium channel blockersLOCKMAN JEFFREY·Filed 2014·Granted May 2, 2017·3 cites·19 claims
- 2671US6958349B2Heteroaryl alkylamide derivatives useful as bradykinin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2003·Granted Oct 25, 2005·5 cites·25 claims
- 2766US7071195B2Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·2 cites·8 claims
- 2865US10774050B2Pyrimidines as sodium channel blockersPURDUE PHARMA LP·Filed 2018·Granted Sep 15, 2020·0 cites·21 claims
- 2965US10550088B26-substituted and 7-substituted morphinan analogs and the use thereofPURDUE PHARMA LP·Filed 2014·Granted Feb 4, 2020·0 cites·10 claims
- 3065US7317025B2Non-peptidic NPY Y2 receptor inhibitorsJOHNSON & JOHNSON PHARM RES·Filed 2004·Granted Jan 8, 2008·2 cites·10 claims
- 3160US9434711B2Sulfonamides as TRPM8 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Sep 6, 2016·0 cites·2 claims
- 3259US2020148646A16-substituted and 7-substituted morphinan analogs and the use thereofPURDUE PHARMA LP·Filed 2020·Application pending·0 cites
- 3358US11180502B2Azaspiro[4.5]decane derivatives and use thereofPURDUE PHARMA LP·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
- 3457US9096521B2Cold menthol receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 4, 2015·0 cites·21 claims
- 3557US9090639B2Cold menthol receptor-1 antagonistsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 28, 2015·0 cites·6 claims
- 3656US2005187291A1Aminotetralin-derived urea modulators of vanilloid VR1 receptorFiled 2005·Application pending·0 cites
- 3755US9884865B2Azaspiro[4.5] decane derivatives and use thereofPURDUE PHARMA LP·Filed 2014·Granted Feb 6, 2018·0 cites·19 claims
- 3854US2008132540A1Non-peptidic npy y2 receptor inhibitorsCARRUTHERS NICHOLAS I·Filed 2007·Application pending·0 cites
- 3952US9862726B2Opioid receptor modulating oxabicyclo[2.2.2]octane morphinansPURDUE PHARMA LP·Filed 2014·Granted Jan 9, 2018·0 cites·22 claims
- 4051US9714252B2Cyclic sulfonamides as sodium channel blockersPURDUE PHARMA LP·Filed 2013·Granted Jul 25, 2017·0 cites·21 claims
- 4151US2004192728A1Quinoline-derived amide modulators of vanilloid VR1 receptorFiled 2004·Application pending·0 cites
- 4250US8629281B2Cold menthol receptor-1 antagonistsCOLBURN RAYMOND W·Filed 2011·Granted Jan 14, 2014·0 cites·34 claims
- 4350US2006052388A1Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disordersDAX SCOTT L·Filed 2005·Application pending·0 cites
- 4449US10196364B2Pyrimidine carboxamides as sodium channel blockersPURDUE PHARMA LP·Filed 2017·Granted Feb 5, 2019·0 cites·19 claims
- 4547US9902726B2Pyridone-sulfone morphinan analogs as opioid receptor ligandsPURDUE PHARMA LP·Filed 2014·Granted Feb 27, 2018·0 cites·19 claims
- 4646US2011190364A1Benzimidazole modulators of vr1PLAYER MARK R·Filed 2011·Application pending·0 cites
- 4746US2011190344A1Benzimidazole modulators of vr1PLAYER MARK R·Filed 2011·Application pending·0 cites
- 4843US11149035B2Chemical compounds as H—PGDS inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 19, 2021·0 cites·16 claims
- 4942US2006223837A1Biaryl derived amide modulators of vanilloid VR1 receptorCODD ELLEN·Filed 2006·Application pending·0 cites
- 5037US10030021B2Spirocyclic morphinans and use thereofPURDUE PHARMA LP·Filed 2015·Granted Jul 24, 2018·0 cites·24 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark A. Youngman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →